Table 1.
Baseline characteristics for the study population in intervention and control arm (standard routine care)
| Characteristic | Total | Study arm | |
|---|---|---|---|
| Intervention | Control | ||
| Demographic | N (%) | n (%) | n (%) |
| Sex | |||
| Male | 543 (49.5) | 287 (52.1) | 256 (46.8) |
| Female | 555 (50.5) | 264 (47.9) | 291 (53.2) |
| Age group | |||
| < 5 years | 650 (59.2) | 327 (59.3) | 323 (59.0) |
| 5 to < 10 years | 269 (24.5) | 136 (24.7) | 133 (24.3) |
| 10 to < 18 years | 113 (10.3) | 53 (9.6) | 60 (11.0) |
| > 18 years | 66 (6.0) | 35 (6.4) | 31 (5.7) |
| Reason of consultation | |||
| Fever | 1098 (100) | 551 (100) | 547 (100) |
| Cough | 364 (33.2) | 168 (30.5) | 196 (35.8) |
| Sneezing and rhinorrhea | 375 (34.2) | 190 (34.5) | 185 (33.8) |
| Headache | 288 (26.2) | 160 (29.0) | 128 (23.4) |
| Abdominal pain | 318 (29.0) | 191 (34.7) | 127 (23.2) |
| Vomiting | 238 (21.7) | 124 (22.5) | 114 (20.8) |
| Sore Throat | 15 (1.4) | 14 (2.5) | 1 (0.2) |
| Ear discharge | 6 (0.5) | 2 (0.4) | 4 (0.7) |
| Diarrhea | 192 (17.5) | 82 (14.9) | 110 (20.1) |
| Dysuria | 4 (0.4) | 1 (0.2) | 3 (0.5) |
| Urinary frequency | 1 (0.1) | 0 (0.0) | 1 (0.2) |
| Loss of sense of smell | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Loss of sense of taste | 8 (0.7) | 8 (1.5) | 0 (0.0) |
| COVID-19 vaccination status | |||
| Fully vaccinated | 53 (4.8) | 27 (4.9) | 26 (4.8) |
| Partially vaccinated | 24 (2.2) | 16 (2.9) | 8 (1.5) |
| Not vaccinated | 1016 (92.5) | 508 (92.2) | 508 (92.9) |
| Unknown | 3 (0.3) | 0 (0.0) | 3 (0.5) |
| Not applicable | 2 (0.2) | 0 (0.0) | 2 (0.4) |
| Respiratory diagnosis | |||
| Yes | 416 (37.9) | 189 (34.3) | 227 (41.5) |
| No | 682 (62.1) | 362 (65.7) | 320 (58.5) |
| Malaria RDT | |||
| Done | 1097 (99.9 | 551 (100) | 546 (99.8) |
| Positive | 571 (52.1%) | 287(52.1) | 284 (52.0%) |